US Patent Granted: Cyclic Peptide Platform
ApexBio has been granted a key patent for its "Synthetic Cyclic Peptide Mimetics," securing the intellectual property rights for our core amyloid-targeting technology.
ApexBio has been granted a key patent for its "Synthetic Cyclic Peptide Mimetics," securing the intellectual property rights for our core amyloid-targeting technology.